Taladua, Weaflare .

HRN: 23-25-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2023
AMPICILLIN 1GM (VIAL)
06/25/2023
06/26/2023
IV
2g
Q6
PROM
Waiting Final Action 
06/25/2023
CEFUROXIME 500MG (TAB)
06/25/2023
07/02/2023
PO
500 Mg Tab
BID
G2 P2 (2002) SP NSVD W Laceration & Repair, MSAF Thinly
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: